IPO Boutique

Fulgent Genetics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Fulgent Genetics, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Fulgent Genetics, Inc.FLGT -
NASDAQ
$12.00-$14.00 $9.00 $9.214.2 million9/29/2016
Credit Suisse, Piper Jaffray, Raymond James
Co-Manager(s):
BTIG
Health Care
Filing(s):

Filed 2016-09-02
Terms Added 2016-09-19
Revised Terms 2016-09-28
Revised Terms 2016-09-28



Fulgent Genetics, Inc. Quote & Chart - Click for current quote - FLGT

About Fulgent Genetics, Inc. (adapted from Fulgent Genetics, Inc. prospectus):
They are a rapidly growing technology company with an initial focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "FLGT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved